Synergy Life Science Launches Water-Based E-cigarette Device in Atlanta
According to PR Newswire, Synergy Life Science, Inc., a company in the health, wellness, and consumer goods industry, recently launched a water-based e-cigarette device called Nebi® in Atlanta, Georgia.
The product claims to use an advanced water-based platform utilizing cutting-edge ultrasonic technology to create safe water vapor without the need for heating or the use of e-liquid.
Chris Gerlach, the CEO of Synergy Life Science, stated:
We are excited to bring Nebi® to the vibrant market of Atlanta. Our goal is to provide a range of high-quality and truly safe e-cigarette products to local tobacco and e-cigarette shops to meet the diverse needs of customers.
According to reports, Synergy Life Science is an innovative company dedicated to consumer health, focusing on developing high-efficiency products by utilizing cannabis derivatives. The company mainly provides high-purity ingredients and groundbreaking technologies for the cannabis CBD market.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
